New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial
26 Oct 2020 //
BIOSPACE
New Efficacy and Biomarker Data From Rivipansel Phase 3 RESET Trial
12 Jun 2020 //
BUSINESSWIRE
GlycoMimetics hit as Pfizer-partnered phase 3 drug flops
06 Aug 2019 //
FIERCE BIOTECH
GlycoMimetics Reports Top-line Results From Pfizer’s Phase 3 Clinical Trial
02 Aug 2019 //
BUSINESSWIRE
Medicines360 & Allergan Present 6Y Clinical Data from Largest Ongoing Ph 3 Study
06 May 2019 //
PR NEWSWIRE
How Sensitive Is Pfizer To R&D Expense Changes?
04 Jul 2018 //
FORBES